EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›DROR

DROR

Dror Ortho-Design, Inc.

Next earnings Aug 12, 2026

Avoid
$0.01
▲ 0.00%
$0.01▼ -54.17%
over 1Y
L $0.00EODHDH $0.04
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W-35.3%
1M+120.0%
3M+107.5%
YTD+10.0%
1Y-54.2%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Watch
Avoid
Conviction
Horizon
Medium (3–12mo)

Revenue grew 156.8% YoY; but unprofitable (net margin -99100.0%).

Revenue (FY2021) $2.57K · FY2021

Dror Ortho-Design, Inc. shows $2.57K in FY2021 revenue (+156.8% YoY), a -99100.0% net margin, and 88.6% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$2.57K————
Gross profit—————
Operating income-$170K-$1.69M-$4.38M-$5.22M-$2.22M
Net income-$171K-$1.68M-$3.57M-$5.78M-$2.54M
Diluted EPS$0.00$0.00-$0.01-$0.01$0.00
Net margin-6639.8%————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$10.5M
EV / EBITDA—
EV / Sales4096.0
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-23.7%
FCF yield-19.2%

Quality & risk

ROIC (est.)—
Free cash flow-$2.06M
Total debt—
Net cash$229K
Altman Z-Score-158.08 distress
Piotroski F-Score2/7

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+2.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 10-Q Quarterly report2026-05-13
  2. 8-K Material agreement2026-05-01
  3. S-1/A Securities registration2026-04-01
  4. 8-K Material agreement2026-03-04
  5. 10-K Annual report2026-02-27
  6. S-1/A Securities registration2026-02-03
  7. 8-K Material agreement2026-01-06
  8. 8-K Material agreement2025-12-08
  9. 10-Q Quarterly report2025-11-18

Recent filings

all on EDGAR ↗
3Period ending 2026-05-012026-06-05open ↗10-QPeriod ending 2026-03-312026-05-13open ↗8-KPeriod ending 2026-04-282026-05-01open ↗S-1/AFiling2026-04-01open ↗8-KPeriod ending 2026-02-262026-03-04open ↗10-KPeriod ending 2025-12-312026-02-27open ↗S-1/AFiling2026-02-03open ↗SCHEDULE 13G/AFiling2026-01-29open ↗8-KPeriod ending 2025-12-302026-01-06open ↗8-KPeriod ending 2025-12-022025-12-08open ↗10-QPeriod ending 2025-09-302025-11-18open ↗NT 10-QPeriod ending 2025-09-302025-11-17open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueF
GrowthA+
ProfitabilityF
Financial healthF
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
Revenue
$2.57K
+156.8% YoY
Net margin
-99100.0%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$2.57K+156.8%
Net income-$2.54M+55.9%
Operating income-$2.22M+57.4%
Diluted EPS$0.00+100.0%
Cash & equivalents$229K-58.4%
Total assets$259K-60.9%
Total liabilities$3.13M+203.9%
Stockholders' equity-$2.87M-680.9%
Op.: -86565.0%L/E: -1.09x

Frequently asked

Is Dror Ortho-Design, Inc. (DROR) a buy?
DROR currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. Revenue grew 156.8% YoY; but unprofitable (net margin -99100.0%).
What is Dror Ortho-Design, Inc.'s quality score?
DROR scores 37.05882352941176/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001282980, latest 10-Q filed 2026-05-13) · EODHD · as of 6/23/2026, 12:44:31 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score37 vs 67
Revenue growth156.8% vs 7.1%
Net margin-99100.0% vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5